← Evidence map

ArticleOncotarget2017

Prexasertib, a cell cycle checkpoint kinases 1 and 2 inhibitor, increases

Ethan Brill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

55 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 29340034